Nothing Special   »   [go: up one dir, main page]

PE20081376A1 - Derivados de pirrolizina, indolizina y quinolizina, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de pirrolizina, indolizina y quinolizina, su preparacion y su aplicacion en terapeutica

Info

Publication number
PE20081376A1
PE20081376A1 PE2007001267A PE2007001267A PE20081376A1 PE 20081376 A1 PE20081376 A1 PE 20081376A1 PE 2007001267 A PE2007001267 A PE 2007001267A PE 2007001267 A PE2007001267 A PE 2007001267A PE 20081376 A1 PE20081376 A1 PE 20081376A1
Authority
PE
Peru
Prior art keywords
pyrrolizine
indolizine
quinolizine
preparation
therapeutics
Prior art date
Application number
PE2007001267A
Other languages
English (en)
Inventor
Gihad Dargazanli
Genevieve Estenne-Bouhtou
Florence Medaisko
Maria-Carmen Renones
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PE20081376A1 publication Critical patent/PE20081376A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DE PIRROLIZINA, INDOLIZINA Y QUINOLIZINA DE FORMULA (I), EN DONDE m Y n SON INDEPENDIENTEMENTE 1 O 2; Ar ES FENILO, NAFTILO-1, NAFTILO-2, PIRIDIN-2-ILO, TIEN-2-ILO, OPCIONALMENTE SUSTITUIDOS CON HALOGENO, ALQUILO(C1-C6), ENTRE OTROS; R ES H O UNO O VARIOS GRUPOS SELECCIONADO DE HALOGENO, MONO O POLIFLUOROALQUILO(C1-C6), ENTRE OTROS. SON SELECCIONADOS: CLORHIDRATO DE TRANS-TREO 2-CLORO-N-[(OCTAHIDROINDOLIZIN-5-IL)FENILMETIL]-3-TRIFLUOROMETILBENZAMIDA, CLORHIDRATO DE TRANS TREO 2,6-DICLORO-N-[(OCTAHIDROINDOLIZIN-5-IL)FENILMETIL]-3-TRIFLUOROMETILBENZAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON INHIBIDORES DE LA GLICINA glyt1, SIENDO UTILES EN EL TRATAMIENTO DE LA DEMENCIA, PSICOSIS, ESQUIZOFRENIA, ANSIEDAD, FOBIAS, MIGRANA, EPILEPSIAS
PE2007001267A 2006-09-22 2007-09-20 Derivados de pirrolizina, indolizina y quinolizina, su preparacion y su aplicacion en terapeutica PE20081376A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0608348A FR2906251B1 (fr) 2006-09-22 2006-09-22 Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PE20081376A1 true PE20081376A1 (es) 2008-11-07

Family

ID=37897398

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001267A PE20081376A1 (es) 2006-09-22 2007-09-20 Derivados de pirrolizina, indolizina y quinolizina, su preparacion y su aplicacion en terapeutica

Country Status (29)

Country Link
US (2) US7776880B2 (es)
EP (1) EP2077837A2 (es)
JP (1) JP2010504311A (es)
KR (1) KR20090080947A (es)
CN (1) CN101573113A (es)
AR (1) AR062896A1 (es)
AU (1) AU2007301880A1 (es)
BR (1) BRPI0717100A2 (es)
CA (1) CA2663080A1 (es)
CL (1) CL2007002732A1 (es)
CO (1) CO6160309A2 (es)
CR (1) CR10658A (es)
EA (1) EA015974B1 (es)
FR (1) FR2906251B1 (es)
GT (1) GT200900061A (es)
HN (1) HN2009000504A (es)
IL (1) IL197500A0 (es)
MA (1) MA30790B1 (es)
ME (1) MEP10109A (es)
MX (1) MX2009003083A (es)
NO (1) NO20091351L (es)
NZ (1) NZ575573A (es)
PE (1) PE20081376A1 (es)
SV (1) SV2009003191A (es)
TN (1) TN2009000082A1 (es)
TW (1) TW200819455A (es)
UY (1) UY30604A1 (es)
WO (1) WO2008037881A2 (es)
ZA (1) ZA200901850B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842804B1 (fr) 2002-07-29 2004-09-03 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861074B1 (fr) * 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
AR075182A1 (es) * 2009-01-28 2011-03-16 Astrazeneca Ab Compuestos 2-aza-biciclo (2.2.2) octano y sus usos
CN102405222A (zh) * 2009-01-28 2012-04-04 阿斯利康(瑞典)有限公司 2-氮杂-二环[2.2.1]庚烷化合物及其用途
US8338441B2 (en) 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
US8143273B2 (en) 2010-06-22 2012-03-27 Hoffman-La Roche Inc. Quinolizidine and indolizidine derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3801636A (en) 1971-08-13 1974-04-02 Abbott Lab 3,4,5-tri-substituted cinnamides
US4409225A (en) * 1981-03-16 1983-10-11 Beecham Group Limited Substituted benzamides
AU2491092A (en) * 1991-09-12 1993-04-05 Smithkline Beecham Plc Azabicyclic compounds as 5-ht4 receptor antagonists
CZ284456B6 (cs) 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
AU2001292936A1 (en) * 2000-09-22 2002-04-02 Ortho-Mcneil Pharmaceutical, Inc. Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
FR2861076B1 (fr) 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
FR2861073B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
WO2008037881A3 (fr) 2008-05-22
TW200819455A (en) 2008-05-01
SV2009003191A (es) 2009-10-27
MA30790B1 (fr) 2009-10-01
HN2009000504A (es) 2011-10-20
GT200900061A (es) 2010-06-21
ZA200901850B (en) 2010-06-30
JP2010504311A (ja) 2010-02-12
US20100267766A1 (en) 2010-10-21
NO20091351L (no) 2009-06-22
AU2007301880A1 (en) 2008-04-03
AR062896A1 (es) 2008-12-10
EP2077837A2 (fr) 2009-07-15
WO2008037881A2 (fr) 2008-04-03
CO6160309A2 (es) 2010-05-20
CR10658A (es) 2009-06-24
MEP10109A (en) 2011-12-20
EA015974B1 (ru) 2012-01-30
FR2906251B1 (fr) 2008-11-07
US7776880B2 (en) 2010-08-17
EA200970312A1 (ru) 2009-12-30
US20090258899A1 (en) 2009-10-15
BRPI0717100A2 (pt) 2013-10-15
CN101573113A (zh) 2009-11-04
NZ575573A (en) 2011-12-22
UY30604A1 (es) 2008-05-02
CA2663080A1 (fr) 2008-04-03
IL197500A0 (en) 2009-12-24
CL2007002732A1 (es) 2008-04-18
KR20090080947A (ko) 2009-07-27
FR2906251A1 (fr) 2008-03-28
TN2009000082A1 (en) 2010-08-19
MX2009003083A (es) 2009-04-02

Similar Documents

Publication Publication Date Title
PE20141059A1 (es) Indazoles
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
PE20141404A1 (es) Derivados de tieno[3,2-d]pirimidina que tienen actividad inhibidora por las quinasas de las proteinas
EA200900213A1 (ru) Ингибиторы обратной транскриптазы вич (варианты), фармацевтическая композиция на их основе, способ ингибирования репликации ретровируса с их помощью и названные ингибиторы для изготовления лекарственного средства для ингибирования обратной транскриптазы вич и для лечения или профилактики инфекционного вич
CO6450621A2 (es) Sulfonamidas nematocidas
PE20171177A1 (es) Compuestos aminopirimidinilo inhibidores de jak
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
PE20120058A1 (es) Derivados de imidazopirazina como inhibidores de syk
PE20191647A1 (es) Acidos propionicos 3-sustituidos como inhibidores de la integrina alfa v
EA201201052A1 (ru) Замещенные нафтиридины и их применение в качестве ингибиторов киназы syk
CR8756A (es) Derivados de acido carboxilico bencimidazolona
PE20060150A1 (es) Antagonistas de cgrp seleccionados, composiciones farmaceuticas y procedimiento para su preparacion
PE20070619A1 (es) TIENO(2,3-b)PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINAS QUINASA
MX352652B (es) Inhibidores de inmunoproteasoma selectivos de derivados del acido alfa-amino boronico.
PE20090370A1 (es) Derivados de heterociclo fusionado como inhibidores de quinasa
CY1108445T1 (el) Νεα μεθοδος συνθεσης και νεα κρυσταλλικη μορφη της αγομελατινης καθως και φαρμακευτικες συνθεσεις που την περιεχουν
TW200606151A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
PE20121327A1 (es) Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello
PE20081376A1 (es) Derivados de pirrolizina, indolizina y quinolizina, su preparacion y su aplicacion en terapeutica
ECSP055910A (es) Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion
AR057770A1 (es) Inhibidores de la p38-map-quinasa y composicion farmaceutica
PE20081159A1 (es) Inhibidores de las quinasas y metodos para su utilizacion
EA201390163A1 (ru) Гетеробициклические производные в качетстве ингибиторов hcv
AR069480A1 (es) Derivados de 2-amino-pirimidina
PE20060957A1 (es) Compuestos pirazolopiridinas su preparacion y composiciones farmaceuticas

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed